Total Matching Records found : 29

India likely to face extreme Covid vaccine shortage from May 1, warn experts -GS Mudur

-The Telegraph Centre’s revised policy has more than doubled the population of potential beneficiaries without immediate provisions for the extra doses needed India is likely to face extreme shortages of Covid-19 vaccines if all adults eligible for vaccination begin queuing up for the jabs from May 1, health and industry experts have said. The Centre’s revised vaccination policy has more than doubled the population of potential vaccine beneficiaries without immediate provisions for the...

More »

India’s decision to liberalise vaccine sales likely to push up prices – and block access to millions -R Ramakumar Besides, by making states responsible for buying vaccines, Modi’s government has deftly deflected possible criticism for future shortages. Over the past few weeks, the second wave of Covid-19 infections and the acute shortage of vaccines had led to considerable public anger against the government. Despite being fully aware of a potential vaccine shortage, the Union government had held back permissions for new vaccines, such as the Sputnik V, to be used in...

More »

How India landed in Covid vaccine mess - GS Mudur

-The Telegraph The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin India’s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government’s lack of funding for key vaccines under development and evaluation, experts have said. The experts, who have tracked global vaccine efforts, said the Indian government’s lack of investments contrasted with the...

More »

India registers over 23,000 new infections

-The Hindu Haryana, Gujarat, Madhya Pradesh, Punjab and Maharashtra are the top States registering a rise in the number of COVID cases India’s indigenous COVID-19 vaccine Covaxin from Hyderabad-based Bharat Biotechis now authorised for emergency use on a par with Oxford-AstraZeneca’s Covishield, NITI Aayog’s member (health) V.K. Paul said on Thursday. India is now seeing a rise in the number of active cases after touching lowest mark in mid-February. Haryana, Gujarat, Madhya Pradesh,...

More »

Recovery from pandemic may take years. Government must invest in welfare projects -Nishtha Tewari

-The Indian Express The current scenario is ideal for policymakers and practitioners to drive home the importance of health spending and institutional development With the first batch of anti-COVID vaccines being rolled out, the mood of the nation seems to be upbeat as it bids farewell to the pain and anguish of last year. The emergency-use approval to the vaccine developed by Oxford University and the Swedish-British pharma major AstraZeneca, manufactured in...

More »

Video Archives


share on Facebook
Read Later

Contact Form

Please enter security code